ipriflavone has been researched along with Adjuvant Arthritis in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ipriflavone was identified to restore AB stainability at 23%." | 1.72 | Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase. ( Imagama, S; Kimata, K; Koike, H; Nishida, Y; Ohkawara, B; Ohno, K; Shinomura, T; Ushida, T; Zhuo, L, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koike, H | 1 |
| Nishida, Y | 1 |
| Shinomura, T | 1 |
| Ohkawara, B | 1 |
| Ohno, K | 1 |
| Zhuo, L | 1 |
| Kimata, K | 1 |
| Ushida, T | 1 |
| Imagama, S | 1 |
1 other study available for ipriflavone and Adjuvant Arthritis
| Article | Year |
|---|---|
Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase.
Topics: Animals; Arthritis, Experimental; Drug Repositioning; Fibroblasts; Hyaluronic Acid; Hyaluronoglucosa | 2022 |